Christopher J Bowman

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Recombinant Human

Top Venues

Birth defects research

Clinical pharmacology and therapeutics

Toxicological sciences : an official journal of the Society of Toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Christopher J Bowman, Sarah N Campion, Natasha R Catlin, William S Nowland, Christine M Stethem, Zaher A Radi, Gregg D Cappon
Reversible effects on female rat fertility with abrocitinib, a Janus kinase 1 inhibitor. Birth defects research 116 (5) (2024)
Christopher J Bowman, Sarah N Campion, Natasha R Catlin, William S Nowland, Christine M Stethem, Zaher A Radi, Gregg D Cappon
Reversible effects on female rat fertility with abrocitinib, a Janus kinase 1 inhibitor. Birth defects research 116 (5) (2024)
Christopher J Bowman, Nathalie Becourt-Lhote, Virginie Boulifard, Rüdiger Cordts, Solange Corriol-Rohou, Brian Enright, Linda Erkman, Jayne Harris, Andreas Hartmann, Jan Hilpert, Sophie Kervyn, Britta Mattson, LaRonda Morford, Mireille Muller, Marcy Powell, Zhanna Sobol, Rajamuthu Srinivasan, Claudia Stark, Kary E Thompson, Katie J Turner, Paul Barrow
Science-Based Approach to Harmonize Contraception Recommendations in Clinical Trials and Pharmaceutical Labels. Clinical pharmacology and therapeutics (2022)
Natasha R Catlin, Christopher J Bowman, Sarah N Campion, Elise M Lewis, William S Nowland, Christine Stethem, Gregg D Cappon
The Postnatal Resolution of Developmental Toxicity Induced by Pharmacological Diacylglycerol Acyltransferase 2 (DGAT2) Inhibition During Gestation in Rats. Toxicological sciences : an official journal of the Society of Toxicology 189 (2) (2022)
Sarah N Campion, Christopher J Bowman, Antje Fuchs, David Karanian, Payal Rana, Gregg D Cappon
Juvenile toxicity study of PF-07256472/recifercept, a recombinant human soluble fibroblast growth factor receptor 3, in 2-3-month-old cynomolgus monkeys. Birth defects research (2022)